Neville Sanjana was recently conferred ‘The New Innovator Award’ as the outstanding Indian American Scientist 2017, by the National Institute of Health (NIH) and its Office of Strategic Coordination’s The Common Fund. Neville is among the seven Indian-American scientists selected for National Institute of Health Awards 2017. A core faculty member at the New York Genome Center and an assistant professor of biology at New York University and of neuroscience and physiology, Neville was selected for his project, ‘In Situ Functional Genomics to Understand Transcriptional Regulation’, which basically utilises new technologies for large-scale DNA synthesis and gene editing which can be applied to gene regulation, cancer evolution and metastasis, drug resistance, cancer immunotherapy, neurodevelopmental disorders and synthetic biology.

Earlier Neville has achieved a doctorate in Brain and Cognitive Sciences from MIT; B.Sc in Symbolic Systems; and a BA in English literature from Stanford University. He has also been a recipient of the ‘Kimmel Scholar’ Award; the ‘Melanoma Research Alliance Young Investigator’ Award; the ‘NIH Pathway to Independence Award’; and the ‘Paul Allen Institute for Brain Science Next Generation Leader’ Award.